Cristiana Pires

Cristiana Pires has a diverse work experience in various roles and positions. Cristiana is currently the Co-Founder and CEO of Asgard Therapeutics since December 2018. Prior to that, they worked as a Postdoctoral Fellow and Guest Researcher at Lund University starting in February 2018. Cristiana also served as a Postdoctoral Fellow at CNC UC since January 2016 and co-founded BRT Blood Reprogramming Technologies Lda in the same year. From September 2014 to December 2015, Cristiana was an Invited Assistant Professor at NOVA Medical School - Faculdade de Ciências Médicas. Cristiana was previously a Research Fellow at CEDOC - CHRONIC DISEASES RESEARCH CENTER from September 2009 to November 2014. Cristiana started their career as a Junior Teaching Assistant at NOVA Medical School - Faculdade de Ciências Médicas from September 2010 to September 2012. Cristiana also worked as a Research Fellow at Universidade de Aveiro from September 2007 to September 2008.

Cristiana Pires has a strong educational background in the field of Life Sciences (Biomedicine field). Cristiana obtained their Doctor of Philosophy (Ph.D.) degree from Universidade Nova de Lisboa between 2009 and 2015. Prior to that, they completed a Graduate Program in the Areas of Basic and Applied Biology (GABBA) at Universidade do Porto in 2009. As for their undergraduate studies, Cristiana Pires earned a Bachelor's Degree in Pharmaceutical Sciences from Universidade do Porto, which they pursued from 2001 to 2007. Additionally, they have obtained a certification in the FELASA B category from the Direção Geral de Veterinária; however, the specific month and year of obtaining this certification are not provided.